Jim Simons acquired 66.3 Thousand Ligand Pharmaceuticals shares worth $4.81 Million. That's 0.01% of their equity portfolio (1306th largest holding). The first Ligand Pharmaceuticals trade was made in Q2 2014. Since then Jim Simons bought shares fourteen more times and sold shares on fifteen occasions. The investor's estimated purchase price is $4.96 Million, resulting in a loss of 3.1%.